120 related articles for article (PubMed ID: 32920168)
1. Attainment of the Patient-acceptable Symptom State in 548 patients with rheumatoid arthritis: Influence of demographic factors.
Duarte C; Santos E; Kvien TK; Dougados M; de Wit M; Gossec L; da Silva JAP
Joint Bone Spine; 2021 Jan; 88(1):105071. PubMed ID: 32920168
[TBL] [Abstract][Full Text] [Related]
2. Lower education and living in countries with lower wealth are associated with higher disease activity in rheumatoid arthritis: results from the multinational COMORA study.
Putrik P; Ramiro S; Keszei AP; Hmamouchi I; Dougados M; Uhlig T; Kvien TK; Boonen A
Ann Rheum Dis; 2016 Mar; 75(3):540-6. PubMed ID: 25630346
[TBL] [Abstract][Full Text] [Related]
3. Associations Between Five Important Domains of Health and the Patient Acceptable Symptom State in Rheumatoid Arthritis and Psoriatic Arthritis: A Cross-Sectional Study of 977 Patients.
Puyraimond-Zemmour D; Etcheto A; Fautrel B; Balanescu A; de Wit M; Heiberg T; Otsa K; Kvien TK; Dougados M; Gossec L
Arthritis Care Res (Hoboken); 2017 Oct; 69(10):1504-1509. PubMed ID: 27998030
[TBL] [Abstract][Full Text] [Related]
4. Defining cut-off values for disease activity states and improvement scores for patient-reported outcomes: the example of the Rheumatoid Arthritis Impact of Disease (RAID).
Dougados M; Brault Y; Logeart I; van der Heijde D; Gossec L; Kvien T
Arthritis Res Ther; 2012 May; 14(3):R129. PubMed ID: 22647431
[TBL] [Abstract][Full Text] [Related]
5. The effect of different remission definitions on identification of predictors of both point and sustained remission in rheumatoid arthritis treated with anti-TNF therapy.
Barnabe C; Homik J; Barr SG; Martin L; Maksymowych WP
J Rheumatol; 2014 Aug; 41(8):1607-13. PubMed ID: 25028371
[TBL] [Abstract][Full Text] [Related]
6. Disparities in rheumatoid arthritis disease activity according to gross domestic product in 25 countries in the QUEST-RA database.
Sokka T; Kautiainen H; Pincus T; Toloza S; da Rocha Castelar Pinheiro G; Lazovskis J; Hetland ML; Peets T; Immonen K; Maillefert JF; Drosos AA; Alten R; Pohl C; Rojkovich B; Bresnihan B; Minnock P; Cazzato M; Bombardieri S; Rexhepi S; Rexhepi M; Andersone D; Stropuviene S; Huisman M; Sierakowski S; Karateev D; Skakic V; Naranjo A; Baecklund E; Henrohn D; Gogus F; Badsha H; Mofti A; Taylor P; McClinton C; Yazici Y
Ann Rheum Dis; 2009 Nov; 68(11):1666-72. PubMed ID: 19643759
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of feet and ankle arthritis and their impact on clinical indices in patients with rheumatoid arthritis: a cross-sectional study.
Lee SW; Kim SY; Chang SH
BMC Musculoskelet Disord; 2019 Sep; 20(1):420. PubMed ID: 31506089
[TBL] [Abstract][Full Text] [Related]
8. Long-term outcomes of patients who rate symptoms of rheumatoid arthritis as 'satisfactory'.
Gwinnutt JM; Hyrich KL; Lunt M; ; Barton A; Verstappen SMM
Rheumatology (Oxford); 2020 Aug; 59(8):1853-1861. PubMed ID: 31729526
[TBL] [Abstract][Full Text] [Related]
9. Factors associated with and cutoff points for Patient Acceptable Symptom State (PASS) in rheumatoid arthritis.
Katchamart W; Narongroeknawin P; Suppa-Udom B; Chanapai W; Srisomnuek A
Clin Rheumatol; 2020 Mar; 39(3):779-786. PubMed ID: 31823142
[TBL] [Abstract][Full Text] [Related]
10. Longitudinal study of clinical prognostic factors in patients with early rheumatoid arthritis: the PREDICT study.
Bird P; Nicholls D; Barrett R; de Jager J; Griffiths H; Roberts L; Tymms K; McCloud P; Littlejohn G;
Int J Rheum Dis; 2017 Apr; 20(4):460-468. PubMed ID: 28205333
[TBL] [Abstract][Full Text] [Related]
11. Validity of the rheumatoid arthritis impact of disease (RAID) score and definition of cut-off points for disease activity states in a population-based European cohort of patients with rheumatoid arthritis.
Salaffi F; Di Carlo M; Vojinovic J; Tincani A; Sulli A; Soldano S; Andreoli L; Dall'Ara F; Ionescu R; Simić Pašalić K; Balčune I; Ferraz-Amaro I; Tlustochowicz M; Butrimienė I; Punceviciene E; Toroptsova N; Grazio S; Morović-Vergles J; Masaryk P; Otsa K; Bernardes M; Boyadzhieva V; Cutolo M
Joint Bone Spine; 2018 May; 85(3):317-322. PubMed ID: 28549945
[TBL] [Abstract][Full Text] [Related]
12. High plasma homocysteine level is associated with increased prevalence of the non-remission state in rheumatoid arthritis: Findings from the KURAMA cohort.
Katsushima M; Minamino H; Shirakashi M; Onishi A; Fujita Y; Yamamoto W; Onizawa H; Tsuji H; Watanabe R; Murakami K; Fujii T; Murata K; Tanaka M; Inagaki N; Morinobu A; Hashimoto M
Mod Rheumatol; 2023 Aug; 33(5):911-917. PubMed ID: 36069659
[TBL] [Abstract][Full Text] [Related]
13. Effects of Sarilumab on Rheumatoid Arthritis as Reported by Patients Using the Rheumatoid Arthritis Impact of Disease Scale.
Gossec L; Strand V; Proudfoot C; Chen CI; Guillonneau S; Kimura T; van Hoogstraten H; Mangan E; Reaney M
J Rheumatol; 2019 Oct; 46(10):1259-1267. PubMed ID: 30877216
[TBL] [Abstract][Full Text] [Related]
14. Identification of disease activity and health status cut-off points for the symptom state acceptable to patients with rheumatoid arthritis.
Heiberg T; Kvien TK; Mowinckel P; Aletaha D; Smolen JS; Hagen KB
Ann Rheum Dis; 2008 Jul; 67(7):967-71. PubMed ID: 17965118
[TBL] [Abstract][Full Text] [Related]
15. Cotreatment with methotrexate in routine care patients with rheumatoid arthritis receiving biological treatment yields better outcomes over time.
Boone NW; Sepriano A; van der Kuy PH; Janknegt R; Peeters R; Landewé RBM
RMD Open; 2019; 5(1):e000836. PubMed ID: 30740244
[TBL] [Abstract][Full Text] [Related]
16. The Patient Experienced Symptom State (PESS): a patient-reported global outcome measure that may better reflect disease remission status.
Duarte C; Santos E; da Silva JAP; Kristianslund EK; Kvien TK; Dougados M; de Wit M; Gossec L; Heiberg T
Rheumatology (Oxford); 2020 Nov; 59(11):3458-3467. PubMed ID: 32375173
[TBL] [Abstract][Full Text] [Related]
17. Factors influencing remission in rheumatoid arthritis patients: results from Karnataka rheumatoid arthritis comorbidity (KRAC) study.
Chandrashekara S; Shobha V; Dharmanand BG; Jois R; Kumar S; Mahendranath KM; Haridas V; Prasad S; Singh Y; Daware MA; Swamy A; Subramanian R; Somashekar SA; Shanthappa AM; Anupama KR
Int J Rheum Dis; 2018 Nov; 21(11):1977-1985. PubMed ID: 27452347
[TBL] [Abstract][Full Text] [Related]
18. Reduced incidence of extra-articular manifestations of RA through effective disease control: Karnataka Rheumatoid Arthritis Comorbidity (KRAC) study.
Chandrashekara S; Shobha V; Dharmanand BG; Jois R; Kumar S; Mahendranath KM; Haridas V; Prasad S; Singh Y; Daware MA; Swamy A; Subramanian R; Somashekar SA; Shanthappa AM; Anupama KR
Int J Rheum Dis; 2017 Nov; 20(11):1694-1703. PubMed ID: 27943575
[TBL] [Abstract][Full Text] [Related]
19. QUEST-RA: quantitative clinical assessment of patients with rheumatoid arthritis seen in standard rheumatology care in 15 countries.
Sokka T; Kautiainen H; Toloza S; Mäkinen H; Verstappen SM; Lund Hetland M; Naranjo A; Baecklund E; Herborn G; Rau R; Cazzato M; Gossec L; Skakic V; Gogus F; Sierakowski S; Bresnihan B; Taylor P; McClinton C; Pincus T;
Ann Rheum Dis; 2007 Nov; 66(11):1491-6. PubMed ID: 17412740
[TBL] [Abstract][Full Text] [Related]
20. Clinical presentation, burden of disease and treatment in young-onset and late-onset rheumatoid arthritis: a matched-pairs analysis taking age and disease duration into account.
Huscher D; Sengler C; Gromnica-Ihle E; Bischoff S; Eidner T; Ochs W; Richter J; Zink A
Clin Exp Rheumatol; 2013; 31(2):256-62. PubMed ID: 23305590
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
